Ginsenoside Compound K Mitigates Mitochondrial Fission Through Bile Acid Receptors/YAP Signaling to Counteract Podocyte Injury in Lupus Nephritis., PMID:40528637
Common Toll-like receptor 7 variants define disease risk and phenotypes in juvenile-onset systemic lupus erythematosus., PMID:40516124
Luminex-based pilot study identifies novel serum autoantibodies associated with disease activity in patients with lupus nephritis., PMID:40500568
Frequency of the AC-2 pattern's new variant (AC-30) and detection of different immunological relationships., PMID:40482790
SLE complicated with Nocardia farcinica bloodstream infection and disseminated nocardiosis: a case report., PMID:40468247
MBD2 promotes B cell differentiation and BCR signaling in systemic lupus erythematosus by regulating the LEF-1-PTEN-PI3K axis., PMID:40467564
Single-centre comparison of non-familial, familial and monogenic lupus., PMID:40465409
Clinically Relevant Cutoffs for Anti-Extractable Nuclear Antigen Line Immunoassays., PMID:40460086
EXPRESS: Diagnostic Discrepancies: A Retrospective Analysis of Two Anti-Nuclear Antibody Platforms., PMID:40459017
Alternation of anti-NMDA receptor subunit GluN2 antibody in a patient with SLE who promptly developed anxiety after belimumab., PMID:40455606
Double Trouble: A Case Report of Hydralazine-Induced Vasculitis and Lupus., PMID:40443627
The role of IL-39 in autoimmune diseases: From general to immunopathogenesis., PMID:40440970
The effects of SARS-CoV-2 vaccines on antinuclear autoantibody formation in individuals without prior COVID-19 infection., PMID:40424949
Anti-mitochondrial antibodies as markers of disease activity in childhood-onset systemic lupus erythematosus: a longitudinal cohort study., PMID:40408235
Targeting Nanotherapeutics for Highly Efficient Diagnosis and Treatment of Systemic Lupus Erythematosus through Regulation of Immune Response., PMID:40395345
Prevalence of and risk factors for important comorbidities of systemic lupus erythematosus using data from a multicenter Chinese cohort registry: A cross-sectional study., PMID:40377765
A serum biomarker panel and miniarray detection system for tracking disease activity and flare risk in lupus nephritis., PMID:40375995
Effect of rituximab on long-term damage acquisition in patients with systemic lupus erythematosus., PMID:40372703
Validation of eight endotypes of lupus based on whole-blood RNA profiles., PMID:40368437
The hidden pathology: An autopsy diagnosis of unsuspected juvenile systemic lupus erythematosus., PMID:40361200
Differences in dynamics of specific anti-nuclear antibodies and their susceptibility to B cell targeting treatment in Systemic Lupus Erythematosus., PMID:40356198
Umbilical cord mesenchymal stem cell-derived secretome as a potential treatment for systemic lupus erythematosus: A double-blind randomized controlled trial., PMID:40352183
Anti-TFAM antibodies link mitochondrial damage with antiphospholipid syndrome and thrombosis in SLE., PMID:40350373
Characterization of anti-neutrophil extracellular traps (NET) antibodies according to systemic lupus erythematosus clinical phenotypes., PMID:40343598
Glucocorticoids discontinuation in systemic lupus erythematosus: a single-centre study., PMID:40342521
Delayed seropositive lupus nephritis: a clinical dilemma., PMID:40341080
Microbial dysbiosis fuels STING-driven autoinflammation through cyclic dinucleotides., PMID:40334619
From Prescription to Predicament: A Case of Semaglutide-Induced Discoid Lupus Erythematosus in an Adult Male Patient., PMID:40330408
Jieduquyuziyin prescription suppresses the activation of the extrafollicular effector B cell by regulating integrin αV signaling in systemic lupus erythematosus., PMID:40318773
Effects of telitacicept in SLE patients with antiphospholipid antibody positivity: a retrospective self-controlled case series., PMID:40317459
Nailfold capillaroscopy changes in systemic lupus erythematosus patients: Correlation with disease activity and anti-uridin1-ribonucleoprotein antibodies., PMID:40316396
Evolutionary trajectory of undifferentiated connective tissue disease and impact of 2019 EULAR/ACR systemic lupus erythematosus classification criteria: insights from a longitudinal study., PMID:40310587
Neutrophil Z Is a Novel Marker to Differentiate Disease Flares From Bacterial Infections in Febrile SLE Patients., PMID:40302194
Validation cohort of a tool to predict proliferative histological class in lupus nephritis based on clinical and laboratory data: LUCAS Study (Lupus Nephritis Class Assessment System)., PMID:40294976
Bilateral Periorbital Erythema and Swelling as an Initial Presentation of Systemic Lupus Erythematosus: A Rare Case., PMID:40289991
The Recurrence of Systemic Diseases in Kidney Transplantation., PMID:40283422
Systemic Lupus Erythematosus Features in Elderly Patients: Case-Based Review., PMID:40283389
Comparative evaluation of three anti-dsDNA antibody detection methods in systemic lupus erythematosus: insights from a large monocentric cohort., PMID:40276498
Proteomics uncovers ICAM2 (CD102) as a novel serum biomarker of proliferative lupus nephritis., PMID:40274316
Outcomes of patients with systemic lupus erythematosus treated with belimumab: a post hoc efficacy analysis of five phase III clinical trials by British Isles Lupus Assessment Group-based Combined Lupus Assessment criteria., PMID:40274305
Collapsing Focal Segmental Glomerulosclerosis With Concurrent IgG4 Nephropathy., PMID:40264599
Autoimmune liver diseases and systemic rheumatic disorders: exploring their interplay and impact on prognosis., PMID:40264008
[The effects of S100A9 gene knockout on lupus-like phenotype in mice]., PMID:40260564
Coexistence of antinucleosome and anti-double-stranded DNA antibodies is associated with severe systemic lupus erythematosus in Tunisian patients., PMID:40245259
False Positive C-ANCA Caused by Antinuclear Antibody: a Case Report and Literature Review., PMID:40209788
Isolated anti-ribosomal P antibodies are associated with reduced risk of renal and articular involvement in systemic lupus erythematosus patients. An observational study from one center., PMID:40206226
Application of machine learning in assessing disease activity in SLE., PMID:40204296
A Retrospective Study of Clinical Characteristics and Serological Profile of Male Systemic Lupus Erythematosus Patients in India., PMID:40200610
A novel IgD-FcδR blocker, IgD-Fc-Ig fusion protein, effectively alleviates abnormal activation of T cells the disease progression in systemic lupus erythematosus., PMID:40194603
Construction and evaluation of glucocorticoid dose prediction model based on genetic and clinical characteristics of patients with systemic lupus erythematosus., PMID:40186486
For research use only. Not for human or drug use.
